The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Basic and Clinical Pharmacology and Toxicology Année : 2017

The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings

Dates et versions

hal-01676317 , version 1 (05-01-2018)

Identifiants

Citer

Adela Taranu, Khalil El Asmar, Romain Colle, Florian Ferreri, Mircea Polosan, et al.. The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings. Basic and Clinical Pharmacology and Toxicology, 2017, 121 (5), pp.435 - 441. ⟨10.1111/bcpt.12827⟩. ⟨hal-01676317⟩
57 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More